Obesity

Vida Health's Obesity Solutions with Integrated Prescribing Capabilities Shows Promising Results

Retrieved on: 
Thursday, March 14, 2024
General Health, Diabetes, Health, Pharmaceutical, Cardiology, Kidney disease, Patient, Obesity, Behavior, Heart, Medical imaging

Vida Health , a leading virtual cardiometabolic clinic, is proud to announce encouraging preliminary results from its innovative virtual obesity solution with integrated prescribing capabilities.

Key Points: 
  • Vida Health , a leading virtual cardiometabolic clinic, is proud to announce encouraging preliminary results from its innovative virtual obesity solution with integrated prescribing capabilities.
  • Part of Vida Health's comprehensive approach to weight management, Vida’s obesity solution integrates personalized lifestyle interventions, medical nutrition therapy, and, when necessary, pharmacotherapy to tackle obesity.
  • "Our early observations are incredibly promising," said Dr. Richard Frank, Chief Medical Officer at Vida Health.
  • "We’re dedicated to transforming obesity care by prioritizing interventions that patients can sustain long-term," stated Joe Murad, CEO of Vida Health.

Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan

Retrieved on: 
Thursday, March 14, 2024
Software, Research, Hardware, Electronic Design Automation, Consumer Electronics, Consumer, Technology, University, Health Technology, Education, Science, Women, Health, Metabolism, Obesity, Environment, Travel, Fazakerley, Female, Systems biology, Wellcome, Lipidomics, National university, Mass spectrometry, Woman, Doctor of Philosophy, Agilent Technologies, Behavior, DSM-IV codes, Pharmaceutical industry

Agilent Technologies Inc. (NYSE: A) announced today that Joycelyn Tan, a Ph.D. student at the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge , UK, has been awarded the 2024 Darlene Solomon Award .

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced today that Joycelyn Tan, a Ph.D. student at the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge , UK, has been awarded the 2024 Darlene Solomon Award .
  • “I am grateful to receive this award from Agilent and FeMS,” said Ms. Tan.
  • Additionally, she will have the opportunity to visit the Agilent Global Solutions Development Center in Singapore, where she will work alongside Agilent scientists.
  • The Darlene Solomon Award is co-sponsored by FeMS (Females in Mass Spectrometry) and Agilent Technologies.

United States Weight Loss Market Report 2024: Market Performance of 2023, Analysis of 2020-2023 & Forecasts to 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 14, 2024
General Health, Pharmaceutical, Fitness & Nutrition, Health, Bankruptcy, Obesity, ALL, Weight loss, Nutrisystem, Fasting, News, Noom, WW, Diet, Pain, FDA, Boston, Physician, Advertising, Dietary supplement

Weight Loss Market: 2024 Status Report & Forecast" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Weight Loss Market: 2024 Status Report & Forecast" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.
  • This report presents a wrap-up of 2023 performance for the U.S. weight loss market during the obesity drugs market explosion and a forecast for 2024.
  • Nearly all non-medical segments of the market have felt the pain of declining sales, and 26,500 weight loss coaches have lost their jobs.
  • However, more physicians are adding weight loss to their practices, bariatric surgeries are hitting new highs, and caseloads/revenues at medical weight loss franchises and at bariatricians are growing.

Iliac Stent Market Size, Share & Trends Analysis Report 2024: A USD 1.53 Billion Market by 2030, Projected to Grow at a CAGR of 5.8% from 2024 to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 14, 2024
Biotechnology, Health, Surgery, Medical Devices, Hospital, NCBI, Obesity, NMPA, Growth, Prevalence, Peripheral artery disease, Getinge Group, Incidence, Patient, Evaluation, PAD, Plaque, Google Images, National Medical Products Administration, Iliac artery, USD, Marketing, Pharmaceutical industry

The global iliac stent market size is expected to reach USD 1.53 billion by 2030, projected to grow at a CAGR of 5.8% from 2024 to 2030.

Key Points: 
  • The global iliac stent market size is expected to reach USD 1.53 billion by 2030, projected to grow at a CAGR of 5.8% from 2024 to 2030.
  • Furthermore, the growing prevalence of peripheral artery disease (PAD) is expected to propel iliac stents market growth.
  • In 2023, North America held the largest share in the iliac stents market, with a revenue share of 43.7%.
  • Hospitals serve as referral centers where patients receive comprehensive care, including diagnostic imaging, medical management, and interventional procedures like iliac stent placement

Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Wednesday, March 13, 2024
Medical Devices, Health, Technology, Mobile, Wireless, Fitness & Nutrition, Artificial Intelligence, Conference, Obesity, Medtech

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the 34th Annual Oppenheimer Healthcare MedTech & Services Conference, taking place on March 12 - 13, 2024, virtually.

Key Points: 
  • Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the 34th Annual Oppenheimer Healthcare MedTech & Services Conference, taking place on March 12 - 13, 2024, virtually.
  • Shantanu Gaur, Allurion’s Chief Executive Officer, and Chris Geberth, Chief Financial Officer, will present today, Wednesday, March 13, 2024 at 4:00 p.m. Eastern Time.
  • Management will also participate in 1x1 meetings.
  • A live webcast of the event will be available on the Allurion website, under Events & Presentations .

Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH

Retrieved on: 
Wednesday, March 13, 2024
Biotechnology, Pharmaceutical, Health, GC, Obesity, Endocrinology, Clinical professor, Associate, Risk, Patient, GCS, Mayo Clinic, Androgen, Șaeș, CAH, Endocrine system, Safety, Workforce, Medical director, ACTH, Pharmaceutical industry

Preliminary pharmacokinetic analysis suggests that tildacerfont is cleared more rapidly in children than in adult CAH patients.

Key Points: 
  • Preliminary pharmacokinetic analysis suggests that tildacerfont is cleared more rapidly in children than in adult CAH patients.
  • 70% of patients with elevated baseline A4 values (16 of 23 patients) demonstrated an A4 reduction at week 4.
  • “The CAHptain-205 study results demonstrate safety and tolerability in pediatric CAH patients with weight-adjusted tildacerfont doses up to 200mg daily.
  • An archived copy of the call will be available on the events section of the company’s investor relations website for approximately 90 days.

Global Enteral Feeding Devices Market Insights 2024-2029 with Avanos Medical and B. Braun Melsungen Leading through Substantial R&D Investments - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 12, 2024
Health, Medical Devices, Other Health, Hospital, Cardiology, Incidence, Enterostomy, Neurology, Conditional sentence, Growth, Prevalence, Obesity, Esophagitis, DSM-IV codes, Patient, Research, GI, Cancer, HEN, Crohn's disease, Ageing, Parenteral nutrition, Syringe, Diet, Gastrointestinal disease, Investment, Malnutrition, Safety, IBS, Dysphagia, USD, Avanos Medical, Tubing (recreation), Pediatrics, PEG

The enteral feeding devices market features diverse players, from well-established giants to dynamic emerging entities, focusing on innovation and strategic growth.

Key Points: 
  • The enteral feeding devices market features diverse players, from well-established giants to dynamic emerging entities, focusing on innovation and strategic growth.
  • Leading firms such as Avanos Medical and B. Braun Melsungen distinguish themselves through substantial research and development (R&D) investments, forming strategic alliances, and initiatives to increase their market share.
  • The enteral feeding devices market is set for sustained growth, driven by healthcare advancements and a global emphasis on chronic disease management and nutritional support.
  • North America, particularly the United States and Canada, leads in the enteral feeding devices market.

Modern Health Announces Support for “Whole Human Health” With the Launch of Physical Well-Being Pathways

Retrieved on: 
Tuesday, March 12, 2024
Science, Other Professional Services, Research, General Health, Health, Mental Health, Professional Services, Other Health, Well, Depression, HR, Obesity, Longevity, Growth, Learning, Diabetes, Conditional sentence, Mental health, Sleep, CBT, Anxiety, Absenteeism, Quality of life, Collection, Risk, Adolescence, American College, Smoking, Cognitive behavioral therapy, DBT, Workforce, Sports medicine, Physical, Nursing

Modern Health , a leading global workplace mental health platform, today announces its latest Pathways Collection focused on Physical Well-Being.

Key Points: 
  • Modern Health , a leading global workplace mental health platform, today announces its latest Pathways Collection focused on Physical Well-Being.
  • In a groundbreaking move for the company, Modern Health is building a future as the only platform to support mental and physical health across all modalities of care.
  • This inaugural launch of its Physical Well-Being Pathways Collection marks the commencement of a detailed product roadmap dedicated to addressing the crucial intersection of physical and mental health.
  • Modern Health’s vision refuses to compartmentalize mental and physical health, instead creating a path toward lasting wellness and longevity.

Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair

Retrieved on: 
Tuesday, March 12, 2024
Health, Medical Devices, Health Technology, Other Health, Fitness & Nutrition, Managed Care, General Health, Penguin Random House, Milena, Obesity, CFO, University, Pitney Bowes, Harvard Business School, Getty Images, Getty, Committee on Finance, DMRC, Audit committee, Management

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of its newest board member and Audit Committee Chair, Milena Alberti-Perez, effective as of March 11, 2024.

Key Points: 
  • Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of its newest board member and Audit Committee Chair, Milena Alberti-Perez, effective as of March 11, 2024.
  • "Milena joins the Allurion board during an exciting time in the company’s history and is a proven and dynamic leader, with deep experience as an operator and board member," said Dr. Shantanu Gaur, Allurion Founder and CEO.
  • She currently serves as Chair of the Audit Committee at Digimarc Corporation (Nasdaq: DMRC) and Chair of the Finance Committee and member of the Audit Committee at Pitney Bowes (NASDAQ: PBI)
    “I am thrilled to join Allurion at a pivotal stage of its journey as a public company,” said Ms. Alberti-Perez.
  • “I am looking forward to working with my fellow board members and the company’s management team as Allurion embarks on setting a new standard for a best-in-class weight loss experience.”
    Ms. Alberti-Perez holds a B.A.

Global Guidewires (Nitinol, Stainless Steel, Others) Market Report 2024: Analysis & Forecasts 2019-2022 and 2023-2029 - Minimally Invasive Techniques Expand, Boosting Guidewire Utilization - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 12, 2024
General Health, Health, Medical Supplies, Medical Devices, Disease, PVI, Friction, ERCP, Coronary artery disease, Conditional sentence, Bacteria, Epidemiology, Specialization, Risk, Investment, Infection, Patient safety, USD, Surgery, Non-communicable disease, Cardiovascular disease, Fungal infection, Obesity, Biotechnology, Peripheral artery disease, Porter's five forces analysis, Diabetes, Chlorhexidine, World Health Organization, Safety, Fatigue, Hypertension, Cardiology, Neurology, Urology, Prevalence, Death, PCI, Diagnosis, Arrhythmia, Temperature, Growth, Incidence, Anatomy, SWOT, Mortality, Stainless steel, WHO, Nickel titanium, Physician, Medical imaging

Guidewires Market is being propelled increasing prevalence of cardiovascular diseases, technological advancements in guidewire design and materials, rising demand for minimally invasive procedures, and expanding healthcare infrastructure in developing economies.

Key Points: 
  • Guidewires Market is being propelled increasing prevalence of cardiovascular diseases, technological advancements in guidewire design and materials, rising demand for minimally invasive procedures, and expanding healthcare infrastructure in developing economies.
  • As the prevalence of risk factors such as obesity, diabetes, and hypertension increase, so does the incidence of cardiovascular diseases.
  • Guidewires are essential tools in percutaneous coronary interventions (PCI), peripheral vascular interventions (PVI), and electrophysiology procedures, driving the demand for guidewires.
  • The increasing prevalence of chronic diseases worldwide drives the demand for guidewires by necessitating minimally invasive interventions for diagnosis and treatment.